About VersaPharm
VersaPharm is a company based in Marietta (United States) founded in 1995 was acquired by Akorn in May 2014. VersaPharm has completed 1 acquisition, including Xanodyne Pharmaceuticals.
- Headquarter Marietta, United States
- SectorsHealthcare
- Website versapharm.com
- Acquired by Akorn (May 2014)
- Investors
- Investments & Acquisitions
- Acquired byAkorn
(May 2014)
Investors in VersaPharm
VersaPharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Akorn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas. | 1948 | akorn.com | Lake, United States |
Investor details for VersaPharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VersaPharm
VersaPharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xanodyne Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of drugs for women's health and pain management | xanodyne.com | Florence, United States | 2001 | Aug 2012 | •••• |
Complete acquisition details for VersaPharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of VersaPharm
3 dated milestones of VersaPharm across 19 years, from founding to its latest funding, stage changes and deals.
- Founded VersaPharm is founded.
- Acquisition Acquires Xanodyne Pharmaceuticals.
- Exit Acquired by Akorn.
Web traffic of VersaPharm
Websites that share an audience with VersaPharm (versapharm.com).
Websites whose visitors overlap most with VersaPharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wdfpharm.com | wdfpharm.com | 100% | – | – | – |
| belcoindia.com | 100% | – | #2,738,256 | View details | |
| cironpharma.com | 100% | 2.4K | #7,858,699 | View details | |
| upsher-smith.com | 100% | 12K | #3,083,070 | View details | |
bosnalijek.com | bosnalijek.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for VersaPharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to VersaPharm
10 companies that operate in the same segment as VersaPharm (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VersaPharm
VersaPharm was founded in 1995.
VersaPharm is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
VersaPharm was founded in 1995 in Marietta, United States, focusing on the generic pharmaceuticals sector. Operations centered on developing and marketing products across categories including dermatology, tuberculosis, and hemophilia. FDA approval was secured for generic injectable rifampin. The company was acquired by Tailwind Capital in 2007 and later sold to Akron, reflecting shifts in ownership within the industry.
VersaPharm has made 1 acquisition, including Xanodyne Pharmaceuticals.
VersaPharm has 1 investor. Key investors include Akorn.
Yes. VersaPharm was acquired by Akorn in May 2014.